Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotechnology Business
Biovail Reports Fourth Quarter and Year-End 2007 Financial Results, Provides Strategy Update
March 29th, 2008
Biovail Corporation (NYSE: BVF) (TSX: BVF) announced financial results for the three-month and 12-month periods ending December 31, 2007. To the extent that this press release contains forward-looking statements, investors are cautioned that these are based on our current views, and actual outcomes are not certain. Please see the note on forward-looking information following the conference-call details below. Total revenues for the three months ended December 31, 2007 were $203.9 million, compared with $307.6 million for the fourth quarter of 2006. Total revenues for the 12 months ended December 31, 2007 were $842.8 million, compared with $1.07 billion for the full year...
Source: Law & Health Weekly (2008-03-29)
|
